IP Library Granted Patent US 10,226,563
Granted Patent B2
US 10,226,563 · App. 12/645,179 · Granted Mar 12, 2019

Methods and systems for treatment of acute ischemic stroke

Inventors: Michi E. Garrison (Half Moon Bay, CA); Tony M. Chou (Hillsborough, CA); Gregory M. Hyde (Menlo Park, CA)
Assignee: Silk Road Medical, Inc.
A61M1/3621A61B17/320725A61M1/3613A61M1/3656A61M1/3659A61M25/0662A61M25/10A61N7/00A61B17/22004A61B2017/320716A61B2017/320733A61F2/013A61M1/3653A61M25/007A61M29/02A61M2025/0031A61M2025/0037A61M2025/0042A61M2025/0681A61M2025/1052A61M2205/7545A61N2007/0043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,563
App. No.
12/645,179
Granted
Mar 12, 2019
Kind
B2
Abstract

Methods and devices are disclosed that enable safe, rapid and relatively short and straight access to the cerebral arteries for the introduction of interventional devices to treat acute ischemic stroke. In addition, the disclosed methods and devices provide means to securely close the access site to the cerebral arteries to avoid the potentially devastating consequences of a transcervical hematoma.

Claims (21)

1. A method for accessing an intracranial artery pursuant to a procedure to treat acute ischemic stroke, comprising:

forming a penetration in a wall of a common carotid artery or internal carotid artery;

applying a closure device at a very beginning of the procedure at a site of the penetration and before placement of any structure through the penetration including an arterial access sheath, the closure device having sutures;

positioning an arterial access sheath having an occlusion element and an inner diameter that is between 7 Fr and 10 Fr through the penetration such that the occlusion element is positioned within the internal carotid artery;

occluding the internal carotid artery;

establishing retrograde blood flow through the internal carotid artery distal of the occluding element;

inserting a distal catheter having an aspiration lumen into the intracranial artery through the access sheath, the distal catheter further having a distal-most end that defines an opening into the aspiration lumen

treating a thrombotic blockage in the intracranial artery by positioning the distal-most end of the distal catheter so that the distal-most end is located immediately adjacent the thrombotic blockage in the intracranial artery;

aspirating blood and/or material from the thrombotic blockage in the intracranial artery into the opening at the distal-most end of the distal catheter such that the aspiration causes the blood and/or material from the thrombotic blockage to flow into the opening at the distal-most end of the distal catheter;

removing the arterial access sheath from the penetration; and

closing the access site with the sutures of the closure device.

2. A method as in claim 1 , wherein establishing retrograde blood flow through the internal carotid artery comprises causing blood to flow into a lumen of the arterial access sheath and into a shunt connected to the access sheath.

3. A method as in claim 2 , further comprising regulating the retrograde blood flow.

4. A method as in claim 2 , further comprising controlling a state of the retrograde blood flow.

5. A method as in claim 2 , further comprising monitoring the retrograde blood flow.

6. A method as in claim 1 , wherein treating a thrombotic blockage further comprises inserting a treatment device through the arterial access sheath and positioning at least a portion of the treatment device in the intracranial artery for the purpose of at least removing or disrupting the thrombotic blockage.

7. A method as in claim 6 , wherein removing the thrombotic blockage further comprises aspirating the thrombotic blockage or debris generated from the thrombotic blockage.

8. A method as in claim 1 , wherein treating a thrombotic blockage further comprises establishing a lumen through the thrombotic blockage.

9. A method as in claim 8 , wherein establishing a lumen comprises implanting a temporary or permanent stent in the thrombotic blockage.

10. A method as in claim 1 , wherein treating a thrombotic blockage further comprises infusing a bolus of thrombolytic drug through the arterial access sheath to the thrombotic blockage in the intracranial artery.

11. A method as in claim 1 , wherein the occlusion element is a balloon.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2019
From: NEUROCO, INC.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 048037/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2016
From: SILK ROAD MEDICAL, INC.
To: NEUROCO, INC.
Reel/Frame 038584/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2010
From: GARRISON, MICHI E.; CHOU, TONY M.; HYDE, GREGORY M.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 024663/0227 →
Continuity (3)
Provisional Application 61140601 · Dec 23, 2008
Provisional Application 61176463 · May 7, 2009
Related Publication 20100217276A1 · Aug 26, 2010
Cited By (5)
US 12,208,279 US 12,285,578 US 12,414,785 US 12,661,490 US 12,685,557